Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.

Bron
Scientific reports - ISSN 2045-2322-15:1 (2025) p. 1-15
Auteur(s)

WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors : type 1 T-lymphocyte responses are associated with clinical outcome

Bron
Journal of hematology and oncology - ISSN 1756-8722-18:1 (2025) p. 1-6
Auteur(s)

Response to letter entitled: Re: Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - a population-based study in Belgium

Bron
European journal of cancer - ISSN 0959-8049-215 (2025) p. 1-3
Auteur(s)
    Roos Leroy, Jolyce Bourgeois, Jean-Luc Canon, Birgit Carly, Evandro de Azambuja, Peter André Van Dam, Liv Veldeman

Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial

Bron
Gynecologic oncology - ISSN 0090-8258-191 (2024) p. 275-286
Auteur(s)
    Emiel A. De Jaeghere, Hannelore Hamerlinck, Sandra Tuyaerts, Lien Lippens, An M.T. Van Nuffel, Regina Baiden-Amissah, Peter Vuylsteke, Stephanie Henry, Xuan Bich Trinh, Peter André Van Dam, Sandrine Aspeslagh, Alex De Caluwe, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen Van de Vijver, Frederic Amant, Katrien Vandecasteel, Bruno Verhasselt, Hannelore G. Denys